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Abstract
            Magnetic resonance (MR) imaging has unparalleled soft-tissue imaging capabilities. The
presence of devices such as pacemakers and implantable cardioverter/defibrillators (ICDs),
however, is historically considered a contraindication to MR imaging. These devices are now
smaller, with less magnetic material and improved electromagnetic interference protection. This
review summarizes the potential hazards of the device-MR environment interaction, and presents
updated information regarding in-vivo and in-vitro experiments. Recent reports on patients with
implantable pacemakers and ICDs who underwent MR scan shows that under certain conditions
patients with these implanted systems may benefit from this imaging modality. The data
presented suggests that certain modern pacemaker and ICD systems may indeed be MR safe.
This may have major clinical implications on current imaging practice.
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Introduction
            
            Magnetic Resonance (MR) imaging is a diagnostic technique used to obtain high quality
images of the human body. The structure and abundance of water in the different tissues of the
human body is the key to clinical MR imaging. The basic concept of MR is the absorption or
emission of electromagnetic energy by atomic nuclei in a static magnetic field after excitation by
a radiofrequency (RF) pulse.1   A powerful magnet generates a magnetic field roughly 10,000
times stronger than the natural background magnetism from the earth. Various types of clinical
MR systems currently use the superconductive magnet which utilizes 0.5 Tesla to 3.0 Tesla. 
            Unlike conventional radiography and computed tomographic imaging, which make use of
potentially  harmful   radiation   (X-rays),   MR   imaging   has   many  advantages,   including   its
nonionizing nature and the unparallel ability to discriminate different soft tissues without contrast
media. MR imaging has now become the image modality of choice for imaging the brain, spine,
musculoskeletal system, head and neck, complex pediatric heart malformations and other tissue
structures.2
More recently, MR imaging has been applied successfully to assess myocardial structure, wall
motion, perfusion and viability. The number of MR scans performed annually has increased
dramatically over the past few years.3-6
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The Growing Problem
            Parallel to the growth and evolution of the MR field, is the burgeoning number of patients
benefiting from implantable cardiac systems including pacemakers and implantable cardioverter-
defibrillatos (ICDs) (Figure1). With new indications for heart failure, innovative device features
and expanded medical coverage; this trend is likely to continue its trajectory. The combination of
these two growing phenomena results in an estimated 50-75% probability of a patient being
indicated for an MR study over the lifetime of their device creating an estimated 200,000 device
patients who were denied the MR scan and more in the future7,8. 
Figure 1: Number of annual MR scans and of newly implanted ICDs in the USA.
            Given the rapid expansion of technology in the fields of both MR imaging and device
arrhythmia management, there is increasing interest in the issue of implantable device safety in
the MR environment. Currently no implantable cardiac device has Food and Drug Agency (FDA)
approval for use in the MR environment and “Do not use magnetic resonance imaging on
patients who have an implanted device” appears on product labels8. The current state of affairs
significantly  limits   the   performance   of   MR   imaging  on   device   patients.   With   a   better
understanding of the hazards of performing MR scans on device patients as well as the
development of MR safe devices, we may soon enter an era where the ability of this imaging
modality may be more widely used to assist in the appropriate diagnosis of patients with devices.
Not only for heart imaging but mainly for brain, spine, and joints as knees and shoulder1,7. 
Hazards and Safety concerns
               Permanent cardiac pacemakers have represented a contraindication to MR imaging.
Strong static, gradient and radiofrequency fields used for MR image creation are thought to be
detrimental to pacemaker function and cause harm to patients undergoing MR examinations. The
multiple potential adverse interactions between pacemakers and MR imaging1,2,9-12 (Table 1)
include heating, rapid atrial pacing, pacing at multiples of the RF pulse and associated rapid
ventricular pacing, reed switch malfunction, asynchronous pacing, inhibition of pacing output,
alteration of programming with potential damage to the pacemaker circuitry or movement of the
device and the potential thermal injury at the lead tip.
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Table 1:  Potential effects of MR imaging on pacemaker and ICD systems
1. Static Magnetic Field
           Mechanical forces on ferromagnetic components
           Unpredictable magnetic sensor activation, Reed-switch closure
           Changes in electrocardiograms
2. Modulated Radio Frequency (RF) Field
           Heating of cardiac tissue adjacent to lead electrodes
           Possible induction of life-threatening arrhythmias
           Pacemaker reprogramming or reset
           RF interactions with the device (over- and under-sensing)
3. Gradient Magnetic Field
           Possible induction of life-threatening arrhythmias 
           Induced voltages on leads cause over- and under-sensing
4. Combined Field Effects
           Alteration of device function due to EMI
           Mechanical forces (vibration)
           Electronic reset of device
            Supporting the current practice comes from several reported lethal consequences of MR
imaging in patients with implanted pacemakers13-15. During the late 1980s incidentally 10 deaths
have been attributed to MR procedures in patients with pacemakers. However these fatalities
were poorly characterized and no electrocardiographic data were available. Most importantly no
deaths have been reported during physician supervised MR procedures in the last decade.
            Despite the above-mentioned concerns, the effects of MR on cardiac pacemakers remain
controversial. Most of the previous studies that prohibit MR in pacemaker patients were based on
in vitro and animal model data in the 1980’s using older pacemaker and lead technology. During
the last decade, anecdotal reports describe a small series16-21 of pacemaker patients who have
safely undergone magnetic resonance scanning (Table 2). Advance in device technology drove
extensive and seminal in-vitro and animal studies of the pacemaker and ICD systems interaction
with the MR, and in recent years, several groups scanned safely larger number of patients.
Table 2: Published reports describing the non-lethal consequences of magnetic resonance
imaging n pacemaker patients (n=number of patients studied; n.a.=data not available;
PM=pacemaker;T=Tesla)
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In-Vitro and Animal Studies:
            The potential hazardous effects of MR imaging in patients with cardiac pacemakers have
been studied since 1983. Pavlicek and colleagues were the first to report the effects of MR
imaging on pacemaker function11. They showed that RF fields present in an MR unit could
possibly inhibit demand pacemakers and time-varying magnetic fields could generate pulse
amplitudes to mimic cardiac activity. The threshold for initiating the asynchronous mode of a
pacemaker was reported to be as low as 17 Gauss (1 Gauss = 10−4 Tesla). The possibility of
altering pacemaker parameters was presented as a serious limitation of MR imaging. Fetter et
al.12 showed that pacemakers reverted from the demand to the asynchronous mode within the
magnetic field of the scanner (0.15 Tesla), but microscopic testing showed no evidence of reed
switch sticking or magnetizing, or damage to other discrete pacemaker components. Other
investigators studied the feasibility of dual-chamber pacing systems in the MR environment.
Erlebacher et al. tested different DDD pacemakers in a saline phantom, and showed that during
scanning at 0.5 Tesla, all units malfunctioned due to RF interference which caused total
inhibition of atrial and ventricular output, or resulted in atrial pacing at very high rates.9 The
potential for rapid cardiac stimulation during MR was also reported in animal studies22. Lauck et
al. investigated the performance of different stimulation modes (VVI, VVIR, VOO, DDD,
DDDR and DOO) during MR scan at 0.5 Tesla23. Reversible activation of the reed switch with
consecutive asynchronous stimulation was observed in all pacemakers. Pacemakers in the
asynchronous mode were not affected with regard to stimulation rate and capture during
scanning.  In  contrast,   pacemakers  with  automatic   mode   switching to  demand pacing  or
programmed inactivation of the reed switch were triggered in the dual chamber mode and were
inhibited in the single chamber mode. Thus, the investigators recommended programming into
the   asynchronous   mode   prior   to   scanning,   and   in   those   without   permanent   pacemaker
dependency, complete inactivation of the system, if possible. 
            The effects of more powerful MR scanners (i.e., 1.5 Tesla) on cardiac pacemakers were
initially reported by Hayes et al24. In-vivo evaluation of different single and dual chamber
pacemakers showed reversion into asynchronous mode and transient reed switch inhibition.
Seven of the eight pulse generators paced rapidly when exposed to the RF signal associated with
a marked decrease in blood pressure. Stimulation cycle length was 200 ms (300 beats/min)
corresponding to the frequency of pulsing. It was proposed that rapid pacing was the result of an
"antenna" effect that couples the RF energy back into the pacemaker output circuits. 
            More recently, Achenbach et al.25 showed in a phantom study on 11 pacemakers and 25
leads that no pacemaker malfunction was observed in asynchronous pacing mode (VOO/DOO),
whereas inhibition and rapid pacing were observed during spin-echo imaging if the pacemakers
were set to VVI or DDD mode. The authors suggested that rapid pacing was caused by induction
of currents above sensing threshold in the atrial lead and consequent triggering of ventricular
stimulation. Direct interference with the pacemaker electronics seemed to be an unlikely
explanation, because the rapid pacing rate was always equal to the programmed frequency limit. 
            Importantly, most of the above were reports of earlier generation pacemakers. Recent
reports testing improved technology devices found no functional issues in most pacemakers
exposed to prolonged MR scan26,27. 
            Measuring lead heat in the MR environment is technically difficult and depends on the
methods used; explaining why several group report different results. Heating effect of pacemaker
leads was investigated by Achenbach et al.25 Continuous registration of the temperature at the
lead tip using an optical temperature sensor showed a maximal temperature increase of 63.1ºC
during 90 seconds of scanning. In seven electrodes, the temperature increase exceeded 15ºC.
Luechinger et al28  used pacemaker leads with additional thermocouple wires as temperature
sensors implanted in nine animals to measure heating. They recorded temperature increases of up
to 20ºC were during MR imaging of the heart. However, they found only minor stimulation
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threshold changes and no pathology and histology heat-induced damage.
            Roguin et al26 found in-vitro, maximal heating of 7ºC. In vivo, when the leads were
inserted into the right ventricle, there was almost no rise in temperature. This was probably due
to the blood flow and heat dissipation. More importantly, in a chronic animal model; of 15 dogs
who had ICD leads implanted and all scanned during prolonged (3-4 hours) MR scans, including
high energy protocols - revealed no heat induced injury. No heat and injury was recently also
reported by a Swiss group27. 
            With regard to force and torque, several studies found that in pacemakers the force in
negligible around 10 grams while with ICD it depends on the year it was manufactured and the
amount of ferromagnetic material. Older devices exert significant forces of 400-500 grams
however most newer ICDs exert around 100 grams26,29.
Human Studies:
Reports using older technology:
            In the earliest years of MR, using older generation pacemakers devices, as mentioned
above there were few anecdotal reports of unexpected deaths in patients undergoing MR
imaging.13-15 In one case, the patient had no escape ventricular rhythm and apparently died due to
systole. Another patient developed ventricular fibrillation during the imaging procedure that was
not recognized immediately because ECG monitoring was not used.30 On the other hand, there
are also reports of pacemaker patients who underwent MR imaging safely (Table 2). 
            Therefore, differences exist among clinicians regarding the perceived safety of scanning
paced patients. In patients who underwent MR imaging of the head, no pacemaker malfunction
was observed with the pacemaker turned off or programmed to an asynchronous pacing mode
prior to MR exposure.16-20  In another study on five patients with pacemakers, Gimbel et al.
reported normal pacemaker performance in four patients during MR (0.35 and 1.5 Tesla)18. One
patient had a pause of approximately two seconds in duration near the completion of MR scan,
the cause of which could not be determined. This occurred in a pacemaker dependent patient
with a unipolar dual chamber device programmed to DOO mode. No rapid cardiac pacing
occurred and no patient reported a torque or heating sensation. Fontaine et al. reported a case of
rapid cardiac pacing during MR imaging (1.5 Tesla) in a patient with a dual chamber
pacemaker.19 The patient developed an irregular ventricular rhythm during RF pulsing which
terminated with the cessation of RF pulsing. MR at 0.5 Tesla was shown to have no influence on
atrial and ventricular stimulation thresholds, P and R wave amplitudes, electrode impedance,
battery voltage, current, and impedance measurements in patients with implanted pacemakers. 
Reports using present technology:
               Vahlhaus et al31  reported their experience using 0.5 Tesla MR system on 34 MR 
examinations in 32 patients with implanted pacemakers and concluded that MR imaging at 0.5
Tesla does not cause irreversible changes in patients' pacemaker systems. Lead impedance and
sensing and stimulation thresholds did not change after MR imaging. Battery voltage decreased
immediately after MR imaging and recovered 3 months later. In a recent study32, the largest
human report so far, 54 non dependent permanent pacemaker patients underwent 64 MR
examinations at 1.5 Tesla . Only 9.4 % of the leads underwent significant threshold changes and
were easily addressed with subtle programming changes. Patient's symptoms and electrographic
changes were mild and transient and did not warrant cessation of MR scan. The authors
concluded that the "performance of unrestricted MR procedures using a 1.5-Tesla MR system
was found to have an acceptable safety profile". They cautioned, however, that the wide variety
of pacing systems and electromagnetic fields used in MR procedures implied that the “absolute
safety of pacemaker and MR interactions cannot be assured". 
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            Schmiedel et al27 from Bonn, Germany, tested the translational forces and temperature
increase (max<2.98ºC) that were in a range which does not represent a safety concern from a
biophysical point of view. They reported their experience with, 63 MR imaging examinations at
1.5 Tesla in 45 patients with implanted pacemakers. Prior to MR the devices were re-
programmed in an asynchronous mode. The maximum Specific absorption rate (SAR) of MR-
sequences was limited to 1.2 W/kg. Continuous monitoring of ECG and pulse oximetry was
performed during MR imaging. No changes to the programmed parameters of the PM or damage
of PM components were observed neither In-vitro (n = 0/24) nor In-vivo (n = 0/63). All patient
studies (n = 63/63) could be completed without any complications. Atrial and ventricular
stimulation thresholds did not change significantly immediately post-MR imaging nor in the 3
months follow-up. They concluded "MR of the brain at 1.5 Tesla can be safely performed in
carefully selected clinical circumstances when appropriate strategies are used (re-programming
the device to an asynchronous mode, continuous monitoring of ECG and pulse oximetry, limiting
the SAR value of the MR sequences, cardiological stand-by). Based on these studies, implanted
pacemaker should not longer be regarded as an absolute contraindication for MR scan at 1.5
Tesla".
            A similar prospective study evaluated the risks of 2.0 T-MR in patients with pacemakers
and concluded that MR imaging in patients implanted with the specific device and leads
evaluated was safe however cautioned that the results may not be applicable to all MR or
pacemaker systems and suggested limited MR exposure to pacemaker patients until larger trials
have been conducted (Roguin, personal communication).
Imaging in Pacemaker Dependent Patients
            Little has been presented regarding MR imaging of pacemaker dependent patients. As
part of a series of five patients, Gimbel et al33 reported one pacemaker dependent patient who
safely underwent cranial MR imaging. Safe inadvertent scanning of pacemaker dependent patient
also has been performed but not published yet [Roguin, personal communication]. The results
suggest that  pacemaker  dependent patients might  also  be offered MR if careful  patient
monitoring and pacemaker reprogramming is performed in concert with use of a transmit receive
coil (in cranial scans) and implementation of specific MR sequences designed to limit power
deposition over the device. A larger series of pacemaker dependent patients need to be evaluated
before a benign outcome can be made.
Safety Issues in Patients with Retained Pacing Leads
               Many patients have endocardial pacemaker leads left in place after pulse generator
removal. The safety of MR in patients with retained endocardial pacemaker wires has not been
systematically investigated to date. However, due to the potential threat that they may act as
“antennas” with significant heating - we feel it is not recommended to scan those patients. 
            Temporary pacing wires, usually made of stainless steel, are sutured to the epicardial
surface of the heart over the right ventricle and right atrium after cardiac surgery, and connected
to   an   external   pacemaker   if   the   patient   develops   bradycardia   or   atrioventricular   block.
Theoretical calculations using a circuit formed by epicardial pacing wires showed induction of
currents up to 80μA by the beating heart in a magnetic field strength of 1.5 Tesla34. Hartnell et
al35 investigated the safety of 1 or 1.5 Tesla MR systems operating with conventional pulse
sequences in 51 patients with retained epicardial pacing wires, cut short at the skin, after cardiac
surgery. None of the patients reported symptoms suggesting arrhythmia or other cardiac
dysfunction during MR imaging, and there were no changes from the baseline ECG rhythms.
Therefore, retained epicardial wires do not seem to present a hazard to patients in the MR
environment. However, this conclusion applies mostly to non-cardiac MR examinations36.
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Imaging  in Patients with Implantable Cardioverter Defibrillators (ICD)
            Although different as in the presence of large capacitors and larger batteries that may
cause higher magnetic forces., pacemakers and ICDs share similar components and thus, to some
extent, their response to the electromagnetic interference (EMI) present during MR scanning
might be expected to be similar1,8,14. Despite dramatic reduction in size and weight, new
generation ICDs have 10 times higher magnetic torque. When tested this was found to be around
100gram/cm as compared to 10 gram/cm for pacemakers. Of note, for older ICDs (late 1990
models) the torque was >300 gram/cm26,27. The implanted device has a fibrotic envelope around
it several weeks after implantation. Forces less than 200 gram will not be felt by the patients26.
ICD   devices   may   falsely  detect   the   MR   RF   noise   as   ventricular   tachyarrhythmia   and
subsequently deliver antitachycardia pacing, cardioversion or defibrillation therapies. In addition,
magnetic fields may prevent detection of ventricular tachycardia or fibrillation. The heating
problem of ICD leads can be expected to be the same as in case of pacemaker leads.
            Despite many pacemaker patients having reportedly undergone MR imaging using a
variety of strategies to allow safe MR scanning, relatively very little has been reported regarding
ICD patients undergoing deliberate MR. An abstract and two case reports37-39 have described the
ill effects of inadvertent MR imaging of ICD patients. Interestingly the same devices were tested
by Roguin et al, and the same findings were found – unable to interrogate these older generation
ICDs26. One case report of an ICD patient inadvertently undergoing MR imaging noted a
substantial rise in pacing thresholds subsequent to the MR exposure40. Concerns over a possible
rise in defibrillation test (DFT) was recently answered by, a recent preliminary report of ICD
patients undergoing MR that showed greater than the 10 J safety margin of safety during post
MR imaging DFT testing32. No thermal injury was found by Roguin et al, in 15 dogs that
underwent prolonged MR scans 4 weeks after ICD implantation26.
            Recently deliberate scanning of ICD patients was reported. Wollmann et al41 report on a
patient with an ICD who intentionally underwent MR imaging of a malignant brain tumor. The
ICD was inactivated by programming the VT-detection and VT/VF-therapy status off. The
patient came through the protocol safely and without any difficulty or discomfort. There was no
arrhythmic event. MR imaging affected neither programmed data nor the function of the ICD
system. Roguin et al42, based on their in-vitro and in-vivo results, implanted an ICD that was
found to be safe, in a young patient with ventricular arrhythmia and suspected ARVD. To
confirm the diagnosis a follow up MR scan was advised. So the patient underwent intentional
MR imaging 6 weeks after implantation. The scan was safe and most of the MR images were of
high quality.
            Gimbel et al43 reported their experience on seven patients who underwent eight MR
imaging scans at 1.5 Tesla. Post-MR scan, all devices demonstrated no change in pacing,
sensing, impedances, charge times, or battery status. None of the patients had any discomfort.
They concluded that scanning of ICD patients might be performed if appropriate reprogramming
and monitoring is implemented. Several patients with the newer biventricular ICD systems, were
safely scanned [Roguin, personal communication].  
            The rapidly accumulating number of safely scanned patients with pacemakers directs one
to surmise that we might also safely scan patients with ICDs if similar strategies that had allowed
safe MR in pacemaker patients were applied to ICD patients. Some investigators26,44  have
suggested that “modern” devices are less prone to the effects of MR and because of better built in
EMI protection circuitry. Disabling the tachy-arrhythmia detection and therapy is one strategy
which has been recommended. Programming to therapy off avoids delivering therapy as a result
of interpretation of noise as tachyarrythmia26. In the study carried out by Gimbel et al,43 simple
strategies that had allowed patients with pacemakers to safely undergo MR imaging were applied
to several ICD patients. 
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Image quality:
     Though lot of studies have been done to determine whether the devices are fully MR imaging-
compatible (function appropriately and without significant image distortion) very little is known
about the fact whether these device are MR-safe (function appropriately in the MR environment
but distort the image) or may not be usable in an MR scanner44,45. Image artifacts and RF noise
can be caused by the presence implanted devices in the MR environment which are in or near the
imaging field of view (such as implants or surface electrodes). These materials produce their own
characteristic static magnetic field that can perturb the relationship between position and
frequency essential to accurate image reconstruction. If the object has a magnetic susceptibility
that is significantly different from that of tissue, distortion will result. Primary concerns with
image artifact and noise include the production of a void where anatomical information is needed
as well as the production of artifacts that may be misdiagnosed as pathology. Schueler et al45
have offered an assessment of image quality according to four criteria: geometric distortion;
susceptibility-induced artifact; warping artifact; and bending, warping, or obliteration of image
contours. 
            Most artifacts from pacemakers and leads result in local image distortion, signal voids, or
increased noise. In an in vitro study26  in a dog model using the clinical scanning protocols this
issue was addressed and image distortion was analyzed by measuring the area where there was a
void in the MR image. The distortion was analyzed at the level of the heart and at the level of the
device. Artifacts due to the devices and leads were observed in some MR sequences and less in
others. Most of the distortion was dependent on scan protocol and image plane:  Fast Spin Echo
and FIESTA sequences had significant distortion.  Fast Gradient Recalled Echo, Tagging and
FSPGR sequences, however, yielded good images. Larger artifacts were observed in image
planes roughly parallel to the planes defined by the device itself. Most distortion was at a
distance of 10-15 cm around the device generator. The authors concluded that image distortion
was dependent on the imaging plane and protocol used. Most image distortion was in the area
adjacent to the device generator. Therefore, organs visualization beyond this distance, such as
knees, lower spine, liver or brain, will not be affected by the presence of the pacemaker or ICD.
Summary: 
               Most researchers in the field agree that although several hundreds of patients with
implanted devices underwent safe MR scan – this does not conclude that MR imaging in patients
with pacemakers or ICDs is indeed safe. According to the FDA’s definition, today’s ICDs are
not  “MR Safe” nor “MR compatible”. Because of the small size of the series and limited to few
manufacturers one cannot conclude that MR imaging can deliberately be performed routinely in
Pacemaker/ICD patients  without  risk.  Further study  is required  to better  understand the
interaction between pacemakers and ICD systems and the effects of MR imaging.  
            Ultimately, a truly “MR safe” ICD system will need to be developed. Nevertheless, one
should be encouraged, and like the experience with pacemakers, the initial encouraging reports of
MR imaging in ICD patients reported only a small series. 
            Like pacemaker patients, ICD patients should not be considered for MR scan unless
appropriate precautions are undertaken and then only when other avenues to acquire clinically
relevant imaging data have been explored.  Should MR imaging be considered in a patient with
an   implantable   device,   appropriate   consultation   with   a   qualified   cardiologist   or
electrophysiologist is strongly advised so that patients can be adequately screened and correctable
physiologic abnormalities (e.g. hypoxia, electrolyte abnormalities, etc.) can be addressed prior to
MR imaging.   The patient must not be pacemaker/ICD dependent. The clinician needs to
document in the chart, that MR imaging is crucial to the management of the patient. No other
imaging can be expected to provide an alternative or has been unsuccessfully tried. The patient or
family will sign a preprinted consent form explaining potential adverse reactions, invalidation of
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warranty, heating leads, rapid pacing, alteration of programming, damage of circuitry requiring
replacement and movement of the device.
            In 2004, the American College of Radiology (ACR) issued an update of its 2001 MR Safe
Practices Guidelines8  in which they reiterate their recommendation that implantable devices
should be a contraindication for MR imaging. They added, however, that decisions for
exceptions should be made on a case-by-case basis and that all MR scans should be performed
under the guidance of both an experienced radiologist and cardiologist/ electrophysiologist, but
noted that "the expertise necessary to safely do so is exceedingly rare throughout the MR industry
today." Thoughtful pre-MR reprogramming, careful monitoring during MR scan and thorough
follow-up must be performed in any device patient considered for MR imaging. Finally a
physician knowledgeable in device therapy and programming should be present throughout the
entire scanning event (Table 3). The authors of the 1.5-T pacemaker study32 agree with the ACR
guidelines that continuous monitoring is needed and that properly trained personnel and
physicians with expertise in adjusting device programming interrogate the devices before and
after the scan. Adherence to these practice guidelines may ensure the implantable cardiac device
patient can safely undergo MR imaging (Table 4). As suggested by the aforementioned studies, it
may be an appropriate time to reconsider whether the presence of an implantable cardiac device
should be an absolute contraindication to MR imaging.
Table 3: Magnetic Resonance Imaging and Pacemakers: Safety Concerns and Guidelines.
* Due to higher degree of interaction between MRI and ICD, the threshold for imaging is higher
than for pacemakers.
Table 4: Technical aspects in MR imaging of patients with pacemakers/ICDs
Arranging the procedure:
Procedure must be approved by attending radiologist 
A Cardiology consult must be obtained to determine pacemaker- or ICD-dependency.
Procedure will be scheduled with Radiology and Cardiology in coordinated fashion.
MR imaging of pacemaker or ICD patients will only be performed in a main Hospital.
The exam will only be performed on weekdays during regular business hours.
Technical (MRI):
Field strength is limited to   1.5 T.
Send/Receive volume coils are preferred over surface coils.
Technical (Pacemaker/ICD):
Device must have been in place preferably for 4-8 weeks prior to MR imaging.
Immediately prior to MR imaging, the pacemaker must be programmed to OFF or must be
programmed to sub threshold outputs (rate response and ventricular rate regulation features will
need to be programmed OFF). ICD programmed to therapy off.
Qualified personnel will perform a full device interrogation prior and immediately after MR scan
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(if patient is an inpatient, it must be done before the patient returns to the floor).
An interrogation of the pacemaker or ICD will be performed 3 months after the exam to measure
thresholds (and other measurements).
Patient Care:
An ACLS certified Cardiology physician, nurse practioner or physician assistant, or alternatively,
an ACLS certified senior resident, fellow or attending physician of the primary care team will be
present at the MR-console during the entire exam to monitor the patient. 
A pacemaker programmer will be present at the MR-scanner.
The patient will be monitored with ECG and pulse oximetry during the entire exam
A crashcart with an external defibrillator-pacemaker (not AED) must be present at the MR-
scanner.
A designated cardiologist needs to be within 5 minutes in of the MR-scanner.
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